Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,945

The DOI matches its Crossref record.

Biomedical applications of collagen

Lee, Chi H., Singla, Anuj, Lee, Yugyung·2001·International Journal of Pharmaceutics
DOI 10.1016/s0378-5173(01)00691-3
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0378-5173(01)00691-3

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 192

  1. Abraham, 2000, Evaluation of the porcine intestinal collagen layer as a biomaterial, J. Biomed. Mater. Res., 51, 442, 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.0.CO;2-4 · doi:10.1002/1097-4636(20000905)51:3<442::aid-jbm19>3.0.co;2-4
  2. Aebischer, 1996, Intrathecal delivery of CNTF using encapsulated genetically modified xenogenic cells in amyotrophic lateral sclerosis, Nat. Med., 2, 696, 10.1038/nm0696-696 · DOI · Paper page
  3. Al-Hendy, 1996, Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts — an alternative approach to somatic gene therapy, Hum. Gene Ther., 6, 165, 10.1089/hum.1995.6.2-165 · DOI
  4. Angella, 2000, Enhanced short-term plasmid transfection of filtration surgery tissues, Invest. Ophthalmol. Vis. Sci., 41, 4158
  5. Aquavella, 1988, Use of collagen shields as a surgical adjunct, J. Cataract Refractive Surg., 14, 492, 10.1016/S0886-3350(88)80004-X · doi:10.1016/s0886-3350(88)80004-x
  6. Assil, 1992, Efficacy of tobramycin — soaked collagen shield vs. tobramycin eyedrop loaden dose for sustained experimental Pseudomonas aeruginosa induced keratitis in rabbits, Am. J. Ophthalmol., 113, 418, 10.1016/S0002-9394(14)76165-3 · doi:10.1016/s0002-9394(14)76165-3
  7. Auger, 1998, Tissue-engineered human skin substitutes developed from collagen populated hydrated gels: clinical and fundamental applications, Med. Biol. Eng. Comput., 36, 801, 10.1007/BF02518887 · DOI
  8. Bank, 2000, The increased swelling and instantaneous deformation of osteoarthritic cartilage is highly correlated with collagen degradation, Arthritis Rheum., 43, 2202, 10.1002/1529-0131(200010)43:10<2202::AID-ANR7>3.0.CO;2-E · doi:10.1002/1529-0131(200010)43:10<2202::aid-anr7>3.0.co;2-e
  9. Barbani, 1995, Bioartificial materials based on collagen: 1. Collagen cross-linking with gaseous glutaraldehyde, J. Biomater. Sci. Polym. Ed., 7, 461, 10.1163/156856295X00535 · DOI
  10. Barr, 1991, Systemic delivery of recombinant proteins by genetically modified myoblasts, Science, 254, 1507, 10.1126/science.1962212 · DOI · Paper page
  11. Baziuk, 1992, Collagen shields and intraocular drug delivery: concentration of gentamicin in the aqueous and vitreous of a rabbit eye after lensectomy and vitrectomy, Int. Ophthalmol., 16, 101, 10.1007/BF00918940 · doi:10.1007/bf00918940
  12. Bell, 1983, The reconstitution of living skin, J. Invest. Dermatol., 81, 2, 10.1111/1523-1747.ep12539993 · DOI · Paper page
  13. Bender, 1996, Efficiency of nanoparticles as a carrier system for antiviral agents in human monocytes/macrophages in vitro, Antimicrob. Agents Chemother., 40, 1467, 10.1128/AAC.40.6.1467 · DOI
  14. Bergeon, 1967, Collagen: a review, J. Okla State Med. Assoc., 60, 330
  15. Berthold, 1998, Collagen microparticles: carriers for glucocorticosteroids, Eur. J. Pharm. Biopharm., 45, 23, 10.1016/S0939-6411(97)00119-7 · doi:10.1016/s0939-6411(97)00119-7
  16. Bloomfield, 1978, Soluble gentamycin ophthalmic inserts as a drug delivery system, Arch. Ophthalmol., 96, 885, 10.1001/archopht.1978.03910050487020 · doi:10.1001/archopht.1978.03910050487020
  17. Boyce, 1998, Skin substitutes from cultured cells and collagen-GAG polymers, Med. Biol. Eng. Comput., 36, 791, 10.1007/BF02518886 · DOI
  18. Boyce, 1988, Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes, J. Biomed. Mater. Res., 22, 939, 10.1002/jbm.820221008 · DOI · Paper page
  19. Boyce, 1992, Biotinylation of implantable collagen for drug delivery, J. Biomed. Mater. Res., 26, 547, 10.1002/jbm.820260410 · DOI
  20. Boyce, 1993, Attachment of an aminoglycoside, amikacin, to implantable collagen for local delivery in wounds, Antimicrob. Agents Chemother., 37, 1890, 10.1128/AAC.37.9.1890 · DOI
  21. Boyce, 1995, Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns, Ann. Surg., 222, 743, 10.1097/00000658-199512000-00008 · DOI · Paper page
  22. Bradley, 1977, Some mechanical property considerations of reconstituted collagen for drug release supports, Biomater. Med. Dev. Artif. Organs, 5, 159, 10.3109/10731197709118671 · DOI
  23. Brauker, 1995, Immunoisolation in somatic cell gene therapy, J. Cell. Biochem., 21B, D1
  24. Browder, 1986, Use of absorbable collagen for hemostasis in general surgical patients, Am. Surg., 52, 492
  25. Cameron, 1978, A new topical hemostatic agent in gynecological surgery, Obstet. Gynecol., 51, 118
  26. Carrol, 1989, Surgical Catgut: the myth of allergy, J. Hand Surg., 14B, 218, 10.1016/0266-7681(89)90131-9 · doi:10.1016/0266-7681(89)90131-9
  27. Cascone, 1995, Blends of synthetic and natural polymers as drug delivery systems for growth hormone, Biomaterials, 16, 569, 10.1016/0142-9612(95)91131-H · DOI · Paper page
  28. Chen, 1990, Cyclosporin-containing collagen shields suppress corneal allograft rejection, Am. J. Ophtalmol., 109, 132, 10.1016/S0002-9394(14)75976-8 · doi:10.1016/s0002-9394(14)75976-8
  29. Chen, 1995, Three dimensional energy-minimized model of human type II smith collagen microfibrill, J. Biomol. Struct. Dyn., 12, 1129, 10.1080/07391102.1995.10508804 · doi:10.1080/07391102.1995.10508804
  30. Chevallay, 2000, Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy, Med. Biol. Eng. Comput., 38, 211, 10.1007/BF02344779 · DOI · Paper page
  31. Chvapil, 1985, Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research, Am. J. Obstet. Gynecol., 151, 325, 10.1016/0002-9378(85)90296-0 · doi:10.1016/0002-9378(85)90296-0
  32. Chvapil, 1993, Collagen fibers as a temporary scaffold for replacement of ACL in goats, J. Biomed. Mater. Res., 27, 313, 10.1002/jbm.820270305 · DOI
  33. Clarke, 1996, Intestine submucosa and polypropylene mesh for abdominal wall repair in dogs, J. Surg. Res., 60, 107, 10.1006/jsre.1996.0018 · DOI · Paper page
  34. Cochran, 2000, Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans, J. Periodontol., 71, 1241, 10.1902/jop.2000.71.8.1241 · DOI · Paper page
  35. Coester, 2000, Gelatin nanoparticles by two step desolvation, a new preparation method, surface modifications and cell uptake, J. Microencapsulation, 17, 187, 10.1080/026520400288427 · DOI · Paper page
  36. Danielsen, 1990, Age-related thermal stability and susceptibility to proteolysis of rat bone collagen, Biochem. J., 272, 697, 10.1042/bj2720697 · DOI
  37. Deatherage, 1987, Packaging and delivery of bone induction factors in a collagenous implant, Collagen Rel. Res., 7, 225, 10.1016/S0174-173X(87)80012-2 · doi:10.1016/s0174-173x(87)80012-2
  38. Desgrandchamps, 2000, Biomaterials in functional reconstruction, Curr. Opin. Urol., 10, 201, 10.1097/00042307-200005000-00003 · doi:10.1097/00042307-200005000-00003
  39. Doillon, 1986, Collagen — based wound dressing effects of hyaluronic acid and fibronectin on wound healing, Biomaterials, 7, 3, 10.1016/0142-9612(86)90080-3 · DOI · Paper page
  40. Dorigo, 1995, Collagen shields delivery of netilmicin: a study of ocular pharmacokinetics, Chemotherapy, 41, 1, 10.1159/000239317 · doi:10.1159/000239317
  41. Dorr, 1982, In vitro retinoid binding and release from a collagen sponge material in a simulated intravaginal environment, J. Biomed. Mater. Res., 16, 839, 10.1002/jbm.820160609 · DOI
  42. El-Samaligy, 1983, Reconstituted collagen nanoparticles, a novel drug carrier delivery system, J. Pharm. Pharmacol., 35, 537, 10.1111/j.2042-7158.1983.tb04831.x · DOI
  43. Farrugia, 1999, Gelatin behavior in dilute aqueous solution: designing a nanoparticulate formulation, J. Pharm. Pharmacol., 51, 643, 10.1211/0022357991772925 · DOI
  44. Fell, 1970, Determination of tablet strength by diametrical compression test, J. Pharm. Sci., 69, 688, 10.1002/jps.2600590523 · DOI · Paper page
  45. Ferkol, 1993, Gene transfer into respiratory epithelial cells by targetting the polymeric immunoglobulin receptor, J. Clin. Invest., 92, 2394, 10.1172/JCI116845 · DOI
  46. Finkelstein, 1991, Further evaluation of collagen shields as a delivery sytem for 5-fluoruracil: histopathological observations, Can. J. Ophthalmol., 26, 129
  47. Fonseca, 1996, Coating liposomes with collagen (Mr 50 000) increases uptake into liver, Biochim. Biophys. Acta, 1279, 259, 10.1016/0005-2736(95)00265-0 · DOI
  48. Friedberg, 1991, Device drug delivery to the eye, Ophthalmology, 98, 725, 10.1016/S0161-6420(91)32227-9 · DOI
  49. Friess, 1998, Collagen-biomaterial for drug delivery, Eur. J. Pharm. Biopharm., 45, 113, 10.1016/S0939-6411(98)00017-4 · DOI · Paper page
  50. Fujioka, 1995, Novel delivery system for proteins using collagen as a carrier material: the minipellet, J. Contr. Release, 33, 307, 10.1016/0168-3659(94)00107-6 · doi:10.1016/0168-3659(94)00107-6
  51. Fujioka, 1998, Protein release from collagen matrices, Adv. Drug. Del. Rev., 31, 247, 10.1016/S0169-409X(97)00119-1 · DOI
  52. Gebhardt, 1995, Collagen as a delivery system for hydrophobic drugs: studies with cyclosporinee, J. Ocul. Pharmacol. Ther., 11, 319, 10.1089/jop.1995.11.319 · doi:10.1089/jop.1995.11.319
  53. Geesin, 1996, Development of a skin model based on insoluble fibrillar collagen, J. Biomed. Mater. Res., 33, 1, 10.1002/(SICI)1097-4636(199621)33:1<1::AID-JBM1>3.0.CO;2-W · doi:10.1002/(sici)1097-4636(199621)33:1<1::aid-jbm1>3.0.co;2-w
  54. Girton, 2000, Mechanisms of stiffening and strengthening in media equivalents fabricated using glycation, J. Biomech. Eng., 122, 216, 10.1115/1.429652 · DOI · Paper page
  55. Gloeckner, 2000, Mechanical evaluation and design of a multilayered collagenous repair, Biomaterial, 52, 365
  56. Gorham, 1992, Effect of chemical modifications on the susceptibility of collagen to proteolysis. II. Dehydrothermal crosslinking, Int. J. Biol. Macromol., 14, 129, 10.1016/S0141-8130(05)80002-9 · DOI
  57. Grammer, 1996, Impregnation of collagen corneal shields with liposomes: uptake and release of hydrophilic and lipophilic marker substances, Curr. Eye Res., 15, 815, 10.3109/02713689609017622 · DOI
  58. Gross, 1963, 5, 307
  59. Gussler, 1990, Collagen shield delivery of trifluorothymidine, J. Cataract Refractive Surg., 16, 719, 10.1016/S0886-3350(13)81013-9 · doi:10.1016/s0886-3350(13)81013-9
  60. Harkness, 1961, Biological functions of collagen, Biol. Rev., 36, 399, 10.1111/j.1469-185X.1961.tb01596.x · DOI · Paper page
  61. Harkness, 1966, Collagen, Sci. Prog. Oxf., 54, 257
  62. Harriger, 1997, Glutaraldehyde crosslinking of collagen substrates inhibits degradation in skin substitutes grafted to athymic mice, J. Biomed. Mater. Res., 35, 137, 10.1002/(SICI)1097-4636(199705)35:2<137::AID-JBM1>3.0.CO;2-O · doi:10.1002/(sici)1097-4636(199705)35:2<137::aid-jbm1>3.0.co;2-o
  63. Harrison, 1989, Collagen corneal shields — an important therapeutic modality, J. Ophthal. Nurs. Technol., 8, 97
  64. Heartlein, 1994, Long-term production and delivery of human growth hormone in vivo, Proc. Natl. Acad. Sci. USA, 91, 10967, 10.1073/pnas.91.23.10967 · DOI
  65. Hobden, 1988, Treatment of experimental pseudomonas keratitis using collagen shields containing tobramycin, Arch. Ophthalmol., 106, 1605, 10.1001/archopht.1988.01060140773053 · doi:10.1001/archopht.1988.01060140773053
  66. Huynh, 1999, Remodeling of an acellular collagen graft into a physiologically responsive neovessel, Nat. Biotechnol., 17, 1083, 10.1038/15062 · DOI · Paper page
  67. Hwang, 1989, Collagen shield enhancement of topical dexamethasone penetration, Arch. Ophthalmol., 107, 1375, 10.1001/archopht.1989.01070020445052 · doi:10.1001/archopht.1989.01070020445052
  68. Jerome, 1992, Editorial: collagen-based, Biomaterials, 9, 137
  69. Jeyanthi, 1990, In vivo biocompatibility of collagen-poly(hydroxyethyl methacrylate) hydrogels, Biomaterials, 11, 238, 10.1016/0142-9612(90)90004-A · DOI
  70. Jeyanthi, 1991, Solid tumour chemotherapy using implantable collagen-poly (HEMA) hydrogel containing 5-fluorouracil, J. Pharm. Pharmacol., 43, 60, 10.1111/j.2042-7158.1991.tb05453.x · doi:10.1111/j.2042-7158.1991.tb05453.x
  71. Katsube, 2000, Repair of articular cartilage defects with cultured chondrocytes in Atelocollagen gel. Comparison with cultured chondrocytes in suspension, Arch. Orthop. Trauma Surg., 120, 121, 10.1007/PL00021232 · DOI
  72. Kaufman, 1988, Collagen shield symposium, J. Cataract Refractive Surg., 14, 487, 10.1016/S0886-3350(88)80002-6 · doi:10.1016/s0886-3350(88)80002-6
  73. Kaufman, 1994, Collagen based drug delivery and artificial tears, J. Ocul. Pharmacol., 10, 17, 10.1089/jop.1994.10.17 · DOI
  74. Kimura, 2000, Bone-inductive efficacy of recombinant human bone morphogenetic protein-2 expressed in Escherichia coli: an experimental study in rat mandibular defects, Scand. J. Plast. Reconstr. Surg. Hand Surg., 34, 289, 10.1080/028443100750059057 · doi:10.1080/028443100750059057
  75. Kobayashi, 2000, Clinical usefulness of crosslinked N-telopeptide of type I collagen as a bone metastatic marker in patients with prostate cancer: comparison with serum PICP, PINP and ICTP, Hinyokika, 46, 869
  76. Kohmura, 1999, BNDF atelocollagen mini-pellet accelerates facial nerve regeneration, Brain Res., 849, 235, 10.1016/S0006-8993(99)02163-0 · DOI
  77. Koide, 1993, A new type of biomaterial for artificial skin: dehydrothermally cross-linked composites of fibrillar and denatured collagens, J. Biomed. Mater. Res., 27, 79, 10.1002/jbm.820270111 · DOI · Paper page
  78. Kuwano, 1997, Effect of collagen cross-linking in collagen corneal shields on occular drug delivery, J. Pharmacol. Ther., 13, 31, 10.1089/jop.1997.13.31 · doi:10.1089/jop.1997.13.31
  79. Kuzuya, 1994, Induction of endothelial cell differentiation in vitro by fibroblast-derived soluble factors, Exp. Cell Res., 215, 310, 10.1006/excr.1994.1347 · doi:10.1006/excr.1994.1347
  80. Lam, 1999, The efficacy of collagen dermis membrane and fibrin on cultured epidermal graft using an athymic mouse model, Ann. Plast. Surg., 43, 523, 10.1097/00000637-199911000-00010 · DOI
  81. Leaders, 1973, New polymers in drug delivery, Ann. Ophthalmol., 5, 513
  82. Lee, 1990, New directions in the optimization of ocular drug delivery, J. Ocul. Pharmacol., 6, 157, 10.1089/jop.1990.6.157 · DOI
  83. Lee, 1998, Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms, J. Biomed. Mater. Res., 42, 30, 10.1002/(SICI)1097-4636(199810)42:1<30::AID-JBM5>3.0.CO;2-P · doi:10.1002/(sici)1097-4636(199810)42:1<30::aid-jbm5>3.0.co;2-p
  84. Lefebvre, 1992, New artificial connective matrix-like structure made of elastin solubilized peptides and collagens: elaboration, biochemical and structural properties, Biomaterials, 13, 28, 10.1016/0142-9612(92)90091-2 · DOI
  85. Lefebvre, 1996, New preparation and microstructure of the EndoPatch elastin–collagen containing glycosaminoglycans, Biomaterials, 17, 1813, 10.1016/0142-9612(95)00346-0 · doi:10.1016/0142-9612(95)00346-0
  86. Leipziger, 1985, Dermal wound repair: role of collagen matrix implants and synthetic polymer dressings, J. Am. Acad. Dermatol., 12, 409, 10.1016/S0190-9622(85)80004-9 · DOI
  87. Liang, 1992, Noncross-linked collagen discs and cross-linked collagen shields in the delivery of gentamicin to rabbit eyes, Invest. Ophthalmol. Vis. Sci., 33, 2194
  88. Liu, 1993, Expression of human factor IX by microencapsulated recombinant fibroblasts, Hum. Gene Ther., 4, 291, 10.1089/hum.1993.4.3-291 · DOI
  89. Lucas, 1989, Ectopic induction of cartilage and bone by water soluble proteins from bovine bone using a collagenous delivery vehicle, J. Biomed. Mater. Res., 23, 23, 10.1002/jbm.820231306 · DOI
  90. Maeda, 1999, Microstructure and release characteristics of the minipellet, a collagen based drug delivery system for controlled release of protein drugs, J. Controlled. Rel., 62, 313, 10.1016/S0168-3659(99)00156-X · DOI · Paper page
  91. Marks, 1991, Effects of fibroblasts and basic fibroblast growth factor on facilitation of dermal wound healing by type I collagen matrices, J. Biomed. Mater. Res., 25, 683, 10.1002/jbm.820250510 · DOI
  92. Marmer, 1988, Therapeutic and protective properties of the corneal shield, J. Cataract Refractive Surg., 14, 496, 10.1016/S0886-3350(88)80005-1 · doi:10.1016/s0886-3350(88)80005-1
  93. Marty, 1978, Nanoparticles-a new colloidal drug delivery system, Pharm. Acta. Helv., 53, 17
  94. Matin-Chouly, 1999, In vitro evaluation of vascular permeability to contrast media using cultured endothelial cell monolayers, Invest. Radiol., 34, 663, 10.1097/00004424-199911000-00001 · doi:10.1097/00004424-199911000-00001
  95. Matsuoka, 1988, Development of an interleukin-2 slow delivery system, Trans. Am. Soc. Artif. Intern. Organs, 34, 729
  96. McPherson, 1986, An examination of the biologic response to injectable, glutaraldehyde cross-linked collagen implants, J. Biomed. Mater. Res., 20, 93, 10.1002/jbm.820200109 · DOI · Paper page
  97. Meaney, 1995, Mechanical properties of implantable biomaterials, Clin. Podiatr. Med. Surg., 12, 363, 10.1016/S0891-8422(23)00947-3 · doi:10.1016/s0891-8422(23)00947-3
  98. Mendicute, 1995, The use of collagen shields impregnated with amphotericin B to treat aspergillus keratomycosis, CLAO J., 21, 252
  99. Milan, 1993, Collagen shields impregnated with gentamicin–dexamethason as a potential drug delivery device, Am.J. Ophthalmol., 116, 622, 10.1016/S0002-9394(14)73206-4 · doi:10.1016/s0002-9394(14)73206-4
  100. Miller, 1964, Clinical observation on use of an extrude collagen suture, Arch. Surg., 88, 167, 10.1001/archsurg.1964.01310200005002 · doi:10.1001/archsurg.1964.01310200005002
  101. Minabe, 1989, Subgingival administration of tetracycline on a collagen film, J. Periodontol., 60, 552, 10.1902/jop.1989.60.10.552 · doi:10.1902/jop.1989.60.10.552
  102. Minabe, 1989, Application of a local drug delivery system to periodontal therapy: I. Development of collagen preparations with immmobilized tetracycline, J. Periodontol., 60, 113, 10.1902/jop.1989.60.2.113 · doi:10.1902/jop.1989.60.2.113
  103. Miyata, 1971, Effects of ultraviolet irradiation on native and telopeptide-poor collagen, Biochem. Biophys. Acta., 229, 672
  104. Miyata, 1992, Collagen engineering for biomaterial use, Clin. Mater., 9, 139, 10.1016/0267-6605(92)90093-9 · doi:10.1016/0267-6605(92)90093-9
  105. Mondino, 1991, Collagen shields, Am. J. Ophthalmol., 112, 587, 10.1016/S0002-9394(14)76863-1 · doi:10.1016/s0002-9394(14)76863-1
  106. Moullier, 1993, Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts, Nat. Genet., 4, 154, 10.1038/ng0693-154 · DOI · Paper page
  107. Moullier, 1993, Continuous systemic secretion of lysosomal enzyme by genetically-modified mouse skin fibroblasts, Transplantation, 56, 427, 10.1097/00007890-199308000-00034 · DOI
  108. Moullier, 1995, Long-term delivery of a lysosomal enzyme by genetically modified fibroblasts in dogs, Nat. Med., 1, 353, 10.1038/nm0495-353 · DOI
  109. Muller, 2000, Solid lipid nanoparticles for controlled drug delivery-a review of the state of the art, Eur. J. Pharm. Biopharm., 50, 161, 10.1016/S0939-6411(00)00087-4 · DOI · Paper page
  110. Mullins, 1996, Allergic reactions to oral, surgical and topical bovine collagen. Anaphylactic risk for surgeons, Austr. New Zealand J. Ophthalmol., 24, 257, 10.1111/j.1442-9071.1996.tb01589.x · DOI
  111. Muniruzzaman, 1998, Complexation of basic fibroblast growth factor with gelatin, J. Biomater. Sci. Polym. Ed., 9, 459, 10.1163/156856298X00569 · doi:10.1163/156856298x00569
  112. Murata, 1999, Bone augmentation by recombinant human BMP-2 and collagen on adult rat parietal bone, Int. J. Oral. Maxillofac. Surg., 28, 232, 10.1016/S0901-5027(99)80144-1 · doi:10.1016/s0901-5027(99)80144-1
  113. Murata, 2000, Bone augmentation by onlay implant using recombinant human BMP-2 and collagen on adult rat skull without periosteum, Clin. Oral Implants Res., 11, 289, 10.1034/j.1600-0501.2000.011004289.x · doi:10.1034/j.1600-0501.2000.011004289.x
  114. Murray, 1990, Collagen shield heparin delivery for prevention of postoperative fibrin, Arch. Ophthalmol., 108, 104, 10.1001/archopht.1990.01070030110039 · doi:10.1001/archopht.1990.01070030110039
  115. Nakagawa, 2000, Ultrastructural study of direct bone formation induced by BMPs-collagen complex implanted into an ectopic site, Oral Dis., 6, 172, 10.1111/j.1601-0825.2000.tb00329.x · doi:10.1111/j.1601-0825.2000.tb00329.x
  116. Narayani, 1994, Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres, J. Microencapsulation, 11, 69, 10.3109/02652049409040439 · DOI
  117. Nicholas, 1997, Denatured thiolated collagen. II. Crosslinking by oxidation, Biomaterials, 18, 815, 10.1016/S0142-9612(97)00003-3 · DOI
  118. O'Brien, 1988, Use of collagen corneal shields versus soft contact lenses to enhance penetration of topical tobramycin, J. Cataract Refractive. Surg., 14, 505, 10.1016/S0886-3350(88)80007-5 · doi:10.1016/s0886-3350(88)80007-5
  119. Ochiya, 1999, New Delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet, Nat. Med., 5, 707, 10.1038/9560 · DOI · Paper page
  120. Orwin, 2000, In vitro culture characteristics of corneal epithelial, endothelial, and keratocyte cells in a native collagen matrix, Tissue Eng., 6, 307, 10.1089/107632700418038 · DOI · Paper page
  121. Pachence, 1987, Collagen: its place in the medical device industry, Med. Device Diagn. Ind., 9, 49
  122. Pajean, 1993, Effect of collagen on liposome permeability, Int. J. Pharm., 91, 209, 10.1016/0378-5173(93)90340-L · DOI
  123. Palmer, 1995, A corneal lens/shield system to promote postoperative corneal epithelial healing, J. Cataract Refractive. Surg., 21, 125, 10.1016/S0886-3350(13)80497-X · doi:10.1016/s0886-3350(13)80497-x
  124. Park, 2000, Type I atelocollagen grafting onto ozone-treated polyurethane films: cell attachment, proliferation, and collagen synthesis, J. Biomed. Mater. Res., 52, 669, 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.0.CO;2-U · doi:10.1002/1097-4636(20001215)52:4<669::aid-jbm11>3.0.co;2-u
  125. Peng, 1986, Cervical tissue uptake of all-trans-retinoic acid delivered via a collagen sponge-cervical cap delivery device in patients with cervical dysplasia, Invest. New Drugs, 4, 245, 10.1007/BF00179591 · doi:10.1007/bf00179591
  126. Petite, 1990, Use of the acyl azide method for crosslinking collagen rich tissues such as pericardium, J. Biomed. Mater. Res., 24, 179, 10.1002/jbm.820240205 · DOI
  127. Phinney, 1988, Collagen shield delivery of gentamicin and vancomycin, Arch. Ophthalmol., 106, 1599, 10.1001/archopht.1988.01060140767052 · DOI
  128. Pleyer, 1994, Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields, Curr. Eye Res., 13, 177, 10.3109/02713689408995775 · doi:10.3109/02713689408995775
  129. Podos, 1972, Pilocarpine therapy with soft contact lenses, Am. J. Ophthalmol., 73, 336, 10.1016/0002-9394(72)90062-1 · doi:10.1016/0002-9394(72)90062-1
  130. Poland, 1988, Clinical uses of collagen shields, J. Cataract Refractive. Surg., 14, 489, 10.1016/S0886-3350(88)80003-8 · doi:10.1016/s0886-3350(88)80003-8
  131. Ponticiello, 2000, Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy, J. Biomed. Mater. Res., 52, 246, 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W · DOI · Paper page
  132. Prajapati, 2000, Mechanical loading regulates protease production by fibroblasts in three dimensional collagen substrates, Wound Repair Regen., 8, 226, 10.1046/j.1524-475x.2000.00226.x · DOI
  133. Ramachandran, 1965, Refinement of the structure of collagen, Biochim. Biophys. Acta., 109, 27, 314, 10.1016/0926-6585(65)90119-6 · doi:10.1016/0926-6585(65)90119-6
  134. Rao, 1995, Recent Developments of Collagen-based materials for medical applications and drug delivery systems, J. Biomater. Sci., 7, 623
  135. Rao, 1992, Effect of crosslinking agent on the release of an aqueous marker from liposomes sequestered in collagen and chitosan gels, J. Membr. Sci., 71, 161, 10.1016/0376-7388(92)85015-B · doi:10.1016/0376-7388(92)85015-b
  136. Reddi, 2000, Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials, Tissue Eng., 6, 351, 10.1089/107632700418074 · DOI · Paper page
  137. Reidy, 1990, The collagen shield: a new vehicle for delivery of cyclosporine A to the eye, Cornea, 9, 196, 10.1097/00003226-199007000-00003 · doi:10.1097/00003226-199007000-00003
  138. Remacle, 1995, Treatment of vocal fold immobility by glutaraldehyde-crosslinked collagen injection: long term results, Ann. Otol. Rhinol. Laryngol., 104, 437, 10.1177/000348949510400604 · doi:10.1177/000348949510400604
  139. Robin, 1990, The effect of collagen shields on rabbit corneal re-epithelization after chemical debridement, Invest. Ophthalmol. Vis. Sci., 31, 1294
  140. Rosenthal, 1997, Collagen as matrix for neo-organ formation by gene-transfected fibroblasts, Anticancer Res., 17, 1179
  141. Rossler, 1994, Effect of Collagen microparticles on the stability of retinol and its absorption into hairless mouse skin in vitro, Pharmazie, 49, 175
  142. Rossler, 1995, Collagen microparticles: preparation and properties, J. Microencapsulation, 12, 49, 10.3109/02652049509051126 · DOI
  143. Royce, 1995, The enhancement of cellular infiltration and vascularization of a collagenous dermal implant in the rat by platelet-derived growth factor BB, J. Cermatol. Sci., 10, 42, 10.1016/0923-1811(95)93713-B · DOI
  144. Rubin, 1973, Collagen as a vehicle for drug delivery, J. Clin. Pharmacol., 13, 309
  145. Ruderman, 1973, Prolonged resorption of collagen sponges: vapor-phase treatment with formaldehyde, J. Biomed. Mater. Res., 7, 263, 10.1002/jbm.820070213 · DOI
  146. Sahai, 1995, An injectable sustained release drug delivery system markedly enhances intratumoral retention of C14-fluorouracil in murine fibro sarcomas, Pharm. Res., 12, S227
  147. Samuel, 1998, Effects of relaxin, pregnancy and parturition on collagen metabolism in the rat public symphysis, J. Endocrinol., 159, 117, 10.1677/joe.0.1590117 · DOI
  148. Sato, 1996, Microdialysis assessment of microfibrous collagen containing a p-glycoprotein-mediated transport inhibitor, cyclosporine A, for local delivery of etopocide, Pharm. Res., 13, 1565, 10.1023/A:1016096016642 · doi:10.1023/a:1016096016642
  149. Sawusch, 1988, Use of collagen corneal shields in the treatment of bacterial keratitis, Am. J. Ophthalmol., 106, 279, 10.1016/0002-9394(88)90361-3 · doi:10.1016/0002-9394(88)90361-3
  150. Sawusch, 1988, Collagen corneal shields enhance penetration of topical prednisolone acetate, J. Cataract Refractive. Surg., 14, 625
  151. Scharfmann, 1991, Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants, Proc. Natl. Acad. Sci. USA, 88, 4626, 10.1073/pnas.88.11.4626 · DOI · Paper page
  152. Schoen, 1992, Antimineralization treatments for bioprosthetic heart valves: assessment of efficacy and safety, J. Thorac. Cardiovasc. Surg., 104, 1285, 10.1016/S0022-5223(19)34619-7 · doi:10.1016/s0022-5223(19)34619-7
  153. Schwartz, 1990, Collagen shield delivery of amphotericin B, Am. J. Ophthalmol., 109, 701, 10.1016/S0002-9394(14)72439-0 · doi:10.1016/s0002-9394(14)72439-0
  154. Sekine, 2001, A new type of surgical adhesive made from porcine collagen and polyglutamic acid, J. Biomed. Mater. Res., 54, 305, 10.1002/1097-4636(200102)54:2<305::AID-JBM18>3.0.CO;2-B · DOI
  155. Sela, 2000, Retinoic acid enhances the effect of collagen on bone union, following induced non-union defect in guinea pig ulna, Inflamm. Res., 49, 679, 10.1007/s000110050646 · doi:10.1007/s000110050646
  156. Shaker, 1989, Effect of collagen shield on cat corneal epithelial wound healing, Invest. Ophthalmol. Vis. Sci., 30, 1565
  157. Shantha, 1993, J. Bioact. Compatible Polym., 8, 142, 10.1177/088391159300800204 · doi:10.1177/088391159300800204
  158. Shortliffe, 1989, Treatment of urinary incontinence by the periurethal implantation of glutaraldehyde crosslinked collagen, J. Urol., 141, 538, 10.1016/S0022-5347(17)40885-8 · doi:10.1016/s0022-5347(17)40885-8
  159. Sobolewski, 1995, Collagen, elastin and glycosaminoglycans in aortic aneurysms, Acta Biochimica. Polonica, 42, 301, 10.18388/abp.1995_4588 · doi:10.18388/abp.1995_4588
  160. Stemberger, 1997, Local treatment of bone and soft tissue infections with the collagen gentamicin sponge, Eur. J. Surg., 578, 17
  161. Stenzel, 1969, Collagen gels: design for vitreous replacement, Science, 164, 1282, 10.1126/science.164.3885.1282 · doi:10.1126/science.164.3885.1282
  162. Stompro, 1989, Attachment of peptide growth factors to implantable collagen, J. Surg. Res., 46, 413, 10.1016/0022-4804(89)90153-4 · DOI
  163. Suh, 2001, Behavior of osteoblasts on a type I atelocollagen grafted ozone oxidized poly l-lactic acid membrane, Biomaterials, 22, 219, 10.1016/S0142-9612(00)00177-0 · DOI
  164. Supp, 1999, Incubation of cultured skin substitutes in reduced humidity promotes cornification in vitro and stable engraftment in athymic mice, Wound Repair Rege., 7, 226, 10.1046/j.1524-475X.1999.00226.x · DOI
  165. Suzuki, 2000, Long-term follow-up study of artificial dermis composed of outer silicone layer and inner collagen sponge, Br. J. Plast. Surg., 53, 659, 10.1054/bjps.2000.3426 · DOI
  166. Takaoka, 1988, Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein, Clin. Orthop., 234, 250, 10.1097/00003086-198809000-00044 · DOI · Paper page
  167. Takenaka, 1986, New Formulations of bioactive materials, Pharm. Tech. Japan, 2, 1083
  168. Tani, 1989, Implantation of fibroblasts transfected with human granulocyte colony-stimulating factor cDNA into mice as a model of cytokine supplement gene therapy, Blood, 74, 1274, 10.1182/blood.V74.4.1274.1274 · doi:10.1182/blood.v74.4.1274.1274
  169. Taravella, 1999, Collagen shield delivery of ofloxacin to the human eye, J. Cataract Refractive. Surg., 25, 562, 10.1016/S0886-3350(99)80056-X · doi:10.1016/s0886-3350(99)80056-x
  170. Thacharodi, 1996, Rate-controlling biopolymer membranes as transdermal delivery systems for nifedipine: development and in vitro evaluations, Biomaterials, 17, 1307, 10.1016/0142-9612(96)88676-5 · doi:10.1016/0142-9612(96)88676-5
  171. Trasciatti, 1998, In vitro effects of different formulations of bovine collagen on cultured human skin, Biomaterials, 19, 897, 10.1016/S0142-9612(97)00175-0 · doi:10.1016/s0142-9612(97)00175-0
  172. Tu, 1993, Kinetic study of collagen fixation with polyepoxy fixatives, J. Biomed. Mater. Res., 27, 3, 10.1002/jbm.820270103 · DOI
  173. Uchio, 2000, Human chondrocyte proliferation and matrix synthesis cultured in Atelocollagen gel, J. Biomed. Mater. Res., 50, 138, 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K · doi:10.1002/(sici)1097-4636(200005)50:2<138::aid-jbm7>3.0.co;2-k
  174. Uitterlinden, 2001, Interaction between the vitamin D receptor gene and collagen type Ialpha 1 gene in susceptibility for fracture, J. Bone Miner. Res., 15, 379, 10.1359/jbmr.2001.16.2.379 · DOI
  175. Ulrich, 2001, Cross linked type I collagen C- and N-telopeptides in women with bone metastases from breast cancer, Arch. Gynecol. Obstet., 264, 186, 10.1007/s004040000105 · doi:10.1007/s004040000105
  176. Unterman, 1988, Collagen shield drug delivery: therapeutic concentrations of tobramycin in the rabbit cornea and aqueous humour, J. Cataract Refractive. Surg., 14, 500, 10.1016/S0886-3350(88)80006-3 · doi:10.1016/s0886-3350(88)80006-3
  177. Van der Laan, 1991, Tee-plasma polymerized dermal sheep collagen for the repair of abdominal wall defects, Int. J. Artif. Organs, 14, 661, 10.1177/039139889101401010 · DOI
  178. Vaneerdeweg, 1998, Comparison between plain and gentamicin containing collagen sponges in infected peritoneal cavity in rats, Eur. J. Surg., 164, 617, 10.1080/110241598750005723 · DOI
  179. Vaneerdeweg, 2000, Effect of gentamicin-containing sponges on the healing of colonic anastomoses in a rat model of peritonitis, Eur. J. Surg., 166, 959, 10.1080/110241500447137 · doi:10.1080/110241500447137
  180. Vardaxis, 1996, Calcification of cross-linked collagen-elastin membrane implants in vivo and their proposed use in bone regeneration, Biomaterials, 17, 1489, 10.1016/0142-9612(96)89773-0 · DOI
  181. Wachol-Drewek, 1996, Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamycin, Biomaterials, 17, 1733, 10.1016/0142-9612(96)87654-X · DOI
  182. Wada, 1999, Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin, Circ. Res., 84, 166, 10.1161/01.RES.84.2.166 · DOI · Paper page
  183. Waltman, 1970, Use of hydrophilic soft lenses to increase ocular penetration of topical drugs, Invest. Ophthalmol., 9, 250
  184. Wang, 1978, Collagen-induced platelet aggregation and release, Biochim. Biophys. Acta., 544, 555, 10.1016/0304-4165(78)90330-6 · DOI
  185. Webster, 1984, Injectable collagen for augmentation of facial areas, Arch. Otolaryngol., 110, 652, 10.1001/archotol.1984.00800360024005 · doi:10.1001/archotol.1984.00800360024005
  186. Wedge, 1992, Collagen shields: efficacy, safety and comfort in the treatment of human traumatic corneal abrasion and effect on vision in healthy eyes, Can. J. Ophthalmol., 27, 295
  187. Weiner, 1985, Liposome-collagen gel matrix, A novel sustained drug delivery system, J. Pharm. Sci., 74, 922, 10.1002/jps.2600740903 · DOI
  188. Willey, 1991, Ocular acyclovir delivery by collagen discs: a mouse model to screen anti-viral agents, Curr. Eye, 10, 167, 10.3109/02713689109020374 · doi:10.3109/02713689109020374
  189. Yamada, 1999, Clinical evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix, Scand. J. Plast. Reconstr. Surg. Hand Surg., 33, 147, 10.1080/02844319950159398 · doi:10.1080/02844319950159398
  190. Yang, 1999, Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain, J. Control. Release, 59, 299, 10.1016/S0168-3659(99)00007-3 · DOI · Paper page
  191. Yannas, 1990, Biologically active analogues of the extracellular matrix: artificial skin and nerves, Angew Chem. Int. Ed., 29, 20, 10.1002/anie.199000201 · DOI
  192. Yannas, 1989, Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin, Proc. Natl. Acad. Sci. USA, 86, 933, 10.1073/pnas.86.3.933 · DOI · Paper page

Cited by

See all 1,945

Metadata

Authors
Lee, C. H., Singla, A., & Lee, Y.
Venue
International Journal of Pharmaceutics
Publisher
Elsevier BV
Published
2001-06
Volume
221
Issue
1-2
Pages
1-22
ISSN
0378-5173 (ISSN-L)
DOI
10.1016/s0378-5173(01)00691-3
OpenAlex
W2147834652
Cited by
1,945
References
0
FWCI
13.71
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biomedical applications of collagen. https://app.cochat.ai/papers/10.1016/s0378-5173(01)00691-3
The paper
Lee, C. H., Singla, A., & Lee, Y. (2001). Biomedical applications of collagen. International Journal of Pharmaceutics. https://doi.org/10.1016/s0378-5173(01)00691-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.